vs

Side-by-side financial comparison of Connect Biopharma Holdings Ltd (CNTB) and NATURAL GAS SERVICES GROUP INC (NGS). Click either name above to swap in a different company.

NATURAL GAS SERVICES GROUP INC is the larger business by last-quarter revenue ($46.1M vs $24.1M, roughly 1.9× Connect Biopharma Holdings Ltd). Connect Biopharma Holdings Ltd runs the higher net margin — 61.6% vs 8.9%, a 52.7% gap on every dollar of revenue.

Connect Biopharma Holdings Ltd is a clinical-stage global biopharmaceutical company dedicated to developing innovative targeted therapies for inflammatory, immunological and autoimmune diseases. Its core pipeline includes candidate treatments for asthma, atopic dermatitis and other conditions with high unmet medical needs, with main operations across the U.S., China and key global markets to deliver effective therapeutic solutions to patients.

Southern Company Gas, formerly AGL Resources, is an American Fortune 500 energy services holding company headquartered in Atlanta, Georgia. The company's operations consist of natural gas distribution, wholesale services, retail operations, and midstream operations. Southern Company Gas is one of the largest natural gas distribution companies in the United States. The company serves approximately 4.5 million utility customers through its regulated distribution subsidiaries across four states....

CNTB vs NGS — Head-to-Head

Bigger by revenue
NGS
NGS
1.9× larger
NGS
$46.1M
$24.1M
CNTB
Higher net margin
CNTB
CNTB
52.7% more per $
CNTB
61.6%
8.9%
NGS

Income Statement — Q2 FY2024 vs Q4 FY2025

Metric
CNTB
CNTB
NGS
NGS
Revenue
$24.1M
$46.1M
Net Profit
$14.8M
$4.1M
Gross Margin
Operating Margin
56.6%
15.4%
Net Margin
61.6%
8.9%
Revenue YoY
13.5%
Net Profit YoY
148.7%
43.2%
EPS (diluted)
$0.27
$0.32

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CNTB
CNTB
NGS
NGS
Q4 25
$46.1M
Q3 25
$43.4M
Q2 25
$41.4M
Q1 25
$41.4M
Q4 24
$40.7M
Q2 24
$24.1M
Q2 23
$0
Net Profit
CNTB
CNTB
NGS
NGS
Q4 25
$4.1M
Q3 25
$5.8M
Q2 25
$5.2M
Q1 25
$4.9M
Q4 24
$2.9M
Q2 24
$14.8M
Q2 23
$-30.5M
Operating Margin
CNTB
CNTB
NGS
NGS
Q4 25
15.4%
Q3 25
24.8%
Q2 25
24.0%
Q1 25
23.0%
Q4 24
14.9%
Q2 24
56.6%
Q2 23
Net Margin
CNTB
CNTB
NGS
NGS
Q4 25
8.9%
Q3 25
13.3%
Q2 25
12.5%
Q1 25
11.7%
Q4 24
7.0%
Q2 24
61.6%
Q2 23
EPS (diluted)
CNTB
CNTB
NGS
NGS
Q4 25
$0.32
Q3 25
$0.46
Q2 25
$0.41
Q1 25
$0.38
Q4 24
$0.22
Q2 24
$0.27
Q2 23
$-0.55

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CNTB
CNTB
NGS
NGS
Cash + ST InvestmentsLiquidity on hand
$110.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$110.9M
$274.7M
Total Assets
$120.6M
$586.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CNTB
CNTB
NGS
NGS
Q4 25
Q3 25
Q2 25
$325.0K
Q1 25
$2.1M
Q4 24
$2.1M
Q2 24
$110.2M
Q2 23
$81.6M
Stockholders' Equity
CNTB
CNTB
NGS
NGS
Q4 25
$274.7M
Q3 25
$271.4M
Q2 25
$266.2M
Q1 25
$260.3M
Q4 24
$255.1M
Q2 24
$110.9M
Q2 23
$128.7M
Total Assets
CNTB
CNTB
NGS
NGS
Q4 25
$586.8M
Q3 25
$562.3M
Q2 25
$525.5M
Q1 25
$501.7M
Q4 24
$492.5M
Q2 24
$120.6M
Q2 23
$144.1M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CNTB
CNTB
NGS
NGS
Operating Cash FlowLast quarter
$-8.0M
$13.9M
Free Cash FlowOCF − Capex
$-20.7M
FCF MarginFCF / Revenue
-44.8%
Capex IntensityCapex / Revenue
74.9%
Cash ConversionOCF / Net Profit
-0.54×
3.38×
TTM Free Cash FlowTrailing 4 quarters
$-58.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CNTB
CNTB
NGS
NGS
Q4 25
$13.9M
Q3 25
$16.8M
Q2 25
$11.0M
Q1 25
$21.3M
Q4 24
$9.4M
Q2 24
$-8.0M
Q2 23
$-31.2M
Free Cash Flow
CNTB
CNTB
NGS
NGS
Q4 25
$-20.7M
Q3 25
$-25.1M
Q2 25
$-14.8M
Q1 25
$2.0M
Q4 24
$-5.1M
Q2 24
Q2 23
FCF Margin
CNTB
CNTB
NGS
NGS
Q4 25
-44.8%
Q3 25
-57.7%
Q2 25
-35.8%
Q1 25
4.9%
Q4 24
-12.6%
Q2 24
Q2 23
Capex Intensity
CNTB
CNTB
NGS
NGS
Q4 25
74.9%
Q3 25
96.5%
Q2 25
62.4%
Q1 25
46.5%
Q4 24
35.8%
Q2 24
Q2 23
Cash Conversion
CNTB
CNTB
NGS
NGS
Q4 25
3.38×
Q3 25
2.90×
Q2 25
2.12×
Q1 25
4.38×
Q4 24
3.29×
Q2 24
-0.54×
Q2 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons